Medpage Today

Heart failure drug Vericiguat, an orally administered soluble guanylate cyclase (sGC) simulator, receives FDA approval

Frontiers in Endocrinology

New study demonstrates association between metformin usage and reduced mortality in diverse populations with COVID-19 and Diabetes

Healio

Study shows US drug prices up to 256% higher than other countries

Diabetes Care

Cohort study demonstrates improved adherence to healthful plant-based diets associated with a lower risk of T2DM

American Diabetes Association

ADA releases 2021 standards of medical care in diabetes centered on evolving evidence, technology, and individualized care

Journal of the American College of Cardiology

Recently EMPA-TROPISM trial demonstrates the benefit of empagliflozin in treating HFrEF nondiabetic patients

The Nexus of Women's Health and Cardiometabolic Risk: Implications Across the Lifespan

February 26, 2021

Dr. Christos S. Mantzoros, MD, DSc, PhD prepares statement from the Endocrine Society on the management of NAFLD/NASH

"CMHC Rewind" showcases videos that spotlight emerging therapeutic strategies with novel mechanisms of action, as well as emerging applications that aim to address key cardiometabolic risk factors and disease pathways.